EPIC-1042

EPIC-1042 is an orally active PTRF inhibitor. EPIC-1042 disrupts the PTRF/Cavin-1-caveolin-1 interaction and inhibits ubiquitination-mediated proteasomal degradation to preserve TAX1BP1. EPIC-1042 promotes the binding of p62 to PARP1 and p62-mediated degradation of PARP1, impairing base excision repair and MGMT recruitment. EPIC-1042 enhances Mitophagy, reduces ROS, and reduces Apoptosis. EPIC-1042 reduces infarct volume after reperfusion injury and improves neurological and cognitive outcomes. EPIC-1042 can be used for research on ischemic stroke and glioblastoma.

For research use only. We do not sell to patients.

  • CAS No.: 372180-55-7
  • Formula: C20H26N6
  • Molecular Weight:350.46
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00